The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective

被引:54
|
作者
Garbaccio, Robert M. [1 ]
Parmee, Emma R. [1 ]
机构
[1] Merck Res Labs, Global Chem, Mailstop 14-2,740 Sumneytown Pike, West Point, PA 19486 USA
来源
CELL CHEMICAL BIOLOGY | 2016年 / 23卷 / 01期
关键词
SMALL-MOLECULE INHIBITORS; PEPTIDASE-IV INHIBITOR; RECEPTOR; TARGET; ANTAGONIST; POTENT; CELLS; AKT; REPLICATION; MK-0657;
D O I
10.1016/j.chembiol.2015.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical probes represent an important component of both academic and pharmaceutical drug discovery research. As a complement to prior reviews that have defined this scientific field, we aim to provide an industry perspective on the value of having high-quality chemical probes throughout the course of preclinical research. By studying examples from the internal Merck pipeline, we recognize that these probes require significant collaborative investment to realize their potential impact in clarifying the tractability and translation of a given therapeutic target. This perspective concludes with recommendations for chemical probe discovery aimed toward maximizing their potential to identify targets that result in the successful delivery of novel therapeutics.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 50 条
  • [22] Future implications of ChatGPT in pharmaceutical industry: drug discovery and development
    Zhao, Ailin
    Wu, Yijun
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [23] Capillary electrophoresis in the pharmaceutical industry: applications in discovery and chemical development
    Hadley, M
    Gilges, M
    Senior, J
    Shah, A
    Camilleri, P
    JOURNAL OF CHROMATOGRAPHY B, 2000, 745 (01): : 177 - 188
  • [24] The Impact of Chemical Biology on Drug Discovery
    Plettenburg, Oliver
    ISRAEL JOURNAL OF CHEMISTRY, 2019, 59 (1-2) : 29 - 36
  • [25] Role of transport proteins in drug discovery and development: a pharmaceutical perspective
    Ayrton, A.
    Morgan, P.
    XENOBIOTICA, 2008, 38 (7-8) : 676 - 708
  • [26] Open resources for chemical probes and their implications for future drug discovery
    Balikci, Esra
    Marques, Anne-Sophie M. C.
    Hansen, Jesper S.
    Huber, Kilian V. M.
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (05) : 505 - 513
  • [27] Open access chemical and clinical probes to support drug discovery
    Edwards, Aled M.
    Bountra, Chas
    Kerr, David J.
    Willson, Timothy M.
    NATURE CHEMICAL BIOLOGY, 2009, 5 (07) : 436 - 440
  • [28] Open access chemical and clinical probes to support drug discovery
    Aled M Edwards
    Chas Bountra
    David J Kerr
    Timothy M Willson
    Nature Chemical Biology, 2009, 5 : 436 - 440
  • [29] Challenges and opportunities in tuberculosis drug discovery: an industry perspective
    Shirude, Pravin S.
    Ramachandran, Sreekanth
    Hosagrahara, Vinayak
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (05) : 499 - 501
  • [30] The promise of open innovation in drug discovery: an industry perspective
    Rees, Steve
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (14) : 1835 - 1838